Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-1090
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Apoptotic Resistance of Metastatic Tumor Cells in Triple Negative Breast Cancer: Roles of Death Receptor-5

Asian Pacific Journal of Cancer Prevention
2019English

HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Role of Immunotherapy in Triple-Negative Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells

Pharmaceutics
Pharmaceutical Science
2018English

TMEPAI Genome Editing in Triple Negative Breast Cancer Cells

Medical Journal of Indonesia
Medicine
2017English

Serum Amyloid a Predisposes Inflammatory Tumor Microenvironment in Triple Negative Breast Cancer

Oncotarget
Oncology
2019English

Lung Cancer Tumorigenicity and Drug Resistance Are Maintained Through ALDHhi CD44hi Tumor Initiating Cells

Oncotarget
Oncology
2013English

Advances in Small-Molecule Drug Discovery for Triple-Negative Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy